CD82 and breast cancer: Moreover, specific degradation of this lncRNA via RNAi (with either constitutive or inducible shRNAs expression) in breast cancer cells or melanoma cells led to a drop in this lncRNA and increase in KAI1 RNA and protein level in both breast cancer MDA-MB-231 and MDA-MB-435 melanoma cells.